Double trouble: Co-occurrence of testosterone deficiency and body fatness associated with all-cause mortality in US men

David Lopez, X. Qiu, S. Advani, K. K. Tsilidis, M. Khera, J. Kim, A. Morgentaler, R. Wang, S. Canfield

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Testosterone deficiency (TD, total testosterone ≤350 ng/dL [12.15 nmol L−1]) and obesity epidemic are growing in parallel in the United States. Yet, the sequelae of TD and obesity on the risk of mortality remain unclear. Objective: To investigate whether the co-occurrence of TD and overall obesity (body mass index ≥30 kg/m2), and abdominal obesity (waist circumference ≥102 cm), is associated with a risk of all-cause mortality in American men. Design: The data were obtained from the NHANES 1999-2004 and the Linked Mortality File (December 31, 2011). A total of 948 participants aged ≥20 years old with endogenous sex hormones and adiposity measurements data were included in this study. Results: Over a median of 9.5 years of follow-up, 142 men died of any cause in this cohort. Multivariable analysis showed a 2.60 fold increased risk of death among men with TD compared with men without TD (Hazard Ratio [HR] = 2.60; 95% confidence interval [CI] = 1.20-5.80). No evidence for interaction between TD and overall or abdominal obesity with risk of death (Pinteraction ≥.80). However, only after comparing men with TD and abdominal obesity with men without TD and no abdominal obesity, we found a 3.30 fold increased risk of death (HR = 3.30, 95% CI = 1.21-8.71). Conclusion: Men with co-occurrence of TD and abdominal obesity have a higher risk of mortality. The effect of co-occurrence of TD and abdominal obesity should be further explored with a larger and longer follow-up time study.

Original languageEnglish (US)
Pages (from-to)58-65
Number of pages8
JournalClinical Endocrinology
Volume88
Issue number1
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Fingerprint

Abdominal Obesity
Testosterone
Mortality
Obesity
Confidence Intervals
Time and Motion Studies
Nutrition Surveys
Adiposity
Gonadal Steroid Hormones
Waist Circumference
Body Mass Index

Keywords

  • all-cause mortality
  • obesity and NHANES
  • testosterone

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Double trouble : Co-occurrence of testosterone deficiency and body fatness associated with all-cause mortality in US men. / Lopez, David; Qiu, X.; Advani, S.; Tsilidis, K. K.; Khera, M.; Kim, J.; Morgentaler, A.; Wang, R.; Canfield, S.

In: Clinical Endocrinology, Vol. 88, No. 1, 01.01.2018, p. 58-65.

Research output: Contribution to journalArticle

Lopez, D, Qiu, X, Advani, S, Tsilidis, KK, Khera, M, Kim, J, Morgentaler, A, Wang, R & Canfield, S 2018, 'Double trouble: Co-occurrence of testosterone deficiency and body fatness associated with all-cause mortality in US men', Clinical Endocrinology, vol. 88, no. 1, pp. 58-65. https://doi.org/10.1111/cen.13501
Lopez, David ; Qiu, X. ; Advani, S. ; Tsilidis, K. K. ; Khera, M. ; Kim, J. ; Morgentaler, A. ; Wang, R. ; Canfield, S. / Double trouble : Co-occurrence of testosterone deficiency and body fatness associated with all-cause mortality in US men. In: Clinical Endocrinology. 2018 ; Vol. 88, No. 1. pp. 58-65.
@article{9f875170b7b24e6ca1847c24f78759da,
title = "Double trouble: Co-occurrence of testosterone deficiency and body fatness associated with all-cause mortality in US men",
abstract = "Background: Testosterone deficiency (TD, total testosterone ≤350 ng/dL [12.15 nmol L−1]) and obesity epidemic are growing in parallel in the United States. Yet, the sequelae of TD and obesity on the risk of mortality remain unclear. Objective: To investigate whether the co-occurrence of TD and overall obesity (body mass index ≥30 kg/m2), and abdominal obesity (waist circumference ≥102 cm), is associated with a risk of all-cause mortality in American men. Design: The data were obtained from the NHANES 1999-2004 and the Linked Mortality File (December 31, 2011). A total of 948 participants aged ≥20 years old with endogenous sex hormones and adiposity measurements data were included in this study. Results: Over a median of 9.5 years of follow-up, 142 men died of any cause in this cohort. Multivariable analysis showed a 2.60 fold increased risk of death among men with TD compared with men without TD (Hazard Ratio [HR] = 2.60; 95{\%} confidence interval [CI] = 1.20-5.80). No evidence for interaction between TD and overall or abdominal obesity with risk of death (Pinteraction ≥.80). However, only after comparing men with TD and abdominal obesity with men without TD and no abdominal obesity, we found a 3.30 fold increased risk of death (HR = 3.30, 95{\%} CI = 1.21-8.71). Conclusion: Men with co-occurrence of TD and abdominal obesity have a higher risk of mortality. The effect of co-occurrence of TD and abdominal obesity should be further explored with a larger and longer follow-up time study.",
keywords = "all-cause mortality, obesity and NHANES, testosterone",
author = "David Lopez and X. Qiu and S. Advani and Tsilidis, {K. K.} and M. Khera and J. Kim and A. Morgentaler and R. Wang and S. Canfield",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/cen.13501",
language = "English (US)",
volume = "88",
pages = "58--65",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Double trouble

T2 - Co-occurrence of testosterone deficiency and body fatness associated with all-cause mortality in US men

AU - Lopez, David

AU - Qiu, X.

AU - Advani, S.

AU - Tsilidis, K. K.

AU - Khera, M.

AU - Kim, J.

AU - Morgentaler, A.

AU - Wang, R.

AU - Canfield, S.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Testosterone deficiency (TD, total testosterone ≤350 ng/dL [12.15 nmol L−1]) and obesity epidemic are growing in parallel in the United States. Yet, the sequelae of TD and obesity on the risk of mortality remain unclear. Objective: To investigate whether the co-occurrence of TD and overall obesity (body mass index ≥30 kg/m2), and abdominal obesity (waist circumference ≥102 cm), is associated with a risk of all-cause mortality in American men. Design: The data were obtained from the NHANES 1999-2004 and the Linked Mortality File (December 31, 2011). A total of 948 participants aged ≥20 years old with endogenous sex hormones and adiposity measurements data were included in this study. Results: Over a median of 9.5 years of follow-up, 142 men died of any cause in this cohort. Multivariable analysis showed a 2.60 fold increased risk of death among men with TD compared with men without TD (Hazard Ratio [HR] = 2.60; 95% confidence interval [CI] = 1.20-5.80). No evidence for interaction between TD and overall or abdominal obesity with risk of death (Pinteraction ≥.80). However, only after comparing men with TD and abdominal obesity with men without TD and no abdominal obesity, we found a 3.30 fold increased risk of death (HR = 3.30, 95% CI = 1.21-8.71). Conclusion: Men with co-occurrence of TD and abdominal obesity have a higher risk of mortality. The effect of co-occurrence of TD and abdominal obesity should be further explored with a larger and longer follow-up time study.

AB - Background: Testosterone deficiency (TD, total testosterone ≤350 ng/dL [12.15 nmol L−1]) and obesity epidemic are growing in parallel in the United States. Yet, the sequelae of TD and obesity on the risk of mortality remain unclear. Objective: To investigate whether the co-occurrence of TD and overall obesity (body mass index ≥30 kg/m2), and abdominal obesity (waist circumference ≥102 cm), is associated with a risk of all-cause mortality in American men. Design: The data were obtained from the NHANES 1999-2004 and the Linked Mortality File (December 31, 2011). A total of 948 participants aged ≥20 years old with endogenous sex hormones and adiposity measurements data were included in this study. Results: Over a median of 9.5 years of follow-up, 142 men died of any cause in this cohort. Multivariable analysis showed a 2.60 fold increased risk of death among men with TD compared with men without TD (Hazard Ratio [HR] = 2.60; 95% confidence interval [CI] = 1.20-5.80). No evidence for interaction between TD and overall or abdominal obesity with risk of death (Pinteraction ≥.80). However, only after comparing men with TD and abdominal obesity with men without TD and no abdominal obesity, we found a 3.30 fold increased risk of death (HR = 3.30, 95% CI = 1.21-8.71). Conclusion: Men with co-occurrence of TD and abdominal obesity have a higher risk of mortality. The effect of co-occurrence of TD and abdominal obesity should be further explored with a larger and longer follow-up time study.

KW - all-cause mortality

KW - obesity and NHANES

KW - testosterone

UR - http://www.scopus.com/inward/record.url?scp=85034607894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034607894&partnerID=8YFLogxK

U2 - 10.1111/cen.13501

DO - 10.1111/cen.13501

M3 - Article

C2 - 29067698

AN - SCOPUS:85034607894

VL - 88

SP - 58

EP - 65

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 1

ER -